Nitric oxide and the pathogenesis of heart muscle disease.
about
The late phase of ischemic preconditioning is abrogated by targeted disruption of the inducible NO synthase gene.Gene therapy with inducible nitric oxide synthase protects against myocardial infarction via a cyclooxygenase-2-dependent mechanism.Nitric oxide induced contractile dysfunction is related to a reduction in myocardial energy generation.
P2860
Nitric oxide and the pathogenesis of heart muscle disease.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Nitric oxide and the pathogenesis of heart muscle disease.
@en
type
label
Nitric oxide and the pathogenesis of heart muscle disease.
@en
prefLabel
Nitric oxide and the pathogenesis of heart muscle disease.
@en
P2093
P2860
P1476
Nitric oxide and the pathogenesis of heart muscle disease.
@en
P2093
Radomski MW
de Belder AJ
P2860
P356
10.1111/J.1365-2362.1995.TB01517.X
P577
1995-01-01T00:00:00Z